| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |